See All Slides - tctmd.com

Slides

Presentation TCTAP 2013

No More Device, Lack of Evidence

Presenter: Ted Feldman

April 24, 2013

Presentation TCTAP 2013

The Future Is: New Antiplatelet Agents, Selective Platelet Function Testing, and Patient-Specific DAPT Duration

Presenter: Matthew J. Price

April 24, 2013

Presentation TCTAP 2013

The Gold Standard for PCI Will Be Bioabsorbable DES

Presenter: Ron Waksman

April 24, 2013

Presentation

Same-Day Discharge After PCI: A Meta-analysis

Presenter: Kimberly M. Brayton

April 23, 2013

Presentation

One-Stop Hybrid Coronary Revascularization (HCR) vs. CABG and PCI for Multivessel Disease

Presenter: L. Shen

April 23, 2013

Presentation

Safe and Feasible Immediate Retransfer of Patients to the Referring Hospital After Acute Coronary Angiography or PCI for ACS

Presenter: Jack Gunnar Andersen

April 22, 2013

Presentation

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

Presenter: Siddharth A. Wayangankar

April 19, 2013

Presentation

Acetylcysteine for the Prevention of Renal Outcomes in Patients with Diabetes Undergoing Coronary and Peripheral Angiography

Presenter: Otavio Berwanger

April 18, 2013

Presentation

Nonsystem Reasons for Delay in Door-to-Balloon (D2B) Time and Associated In-Hospital Mortality

Presenter: Rajesh V. Swaminathan

April 18, 2013

Presentation Fellows 2013

TAVR: Indications, Outcomes, and Complications

Presenter: Susheel Kodali

April 17, 2013

Advertisement

Slides

No More Device, Lack of Evidence

The Future Is: New Antiplatelet Agents, Selective Platelet Function Testing, and Patient-Specific DAPT Duration

The Gold Standard for PCI Will Be Bioabsorbable DES

Same-Day Discharge After PCI: A Meta-analysis

One-Stop Hybrid Coronary Revascularization (HCR) vs. CABG and PCI for Multivessel Disease

Safe and Feasible Immediate Retransfer of Patients to the Referring Hospital After Acute Coronary Angiography or PCI for ACS

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

Acetylcysteine for the Prevention of Renal Outcomes in Patients with Diabetes Undergoing Coronary and Peripheral Angiography

Nonsystem Reasons for Delay in Door-to-Balloon (D2B) Time and Associated In-Hospital Mortality

TAVR: Indications, Outcomes, and Complications

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content